National Health Investors, Inc. filed a Form 8-K with the SEC on August 27, 2026, disclosing that it entered into a Change in Control Severance Agreement with executive Christian Maingot, effective the same date.
Key Highlights
- Agreement date: The Change in Control Severance Agreement between National Health Investors, Inc. and Christian Maingot is effective August 27, 2026.
- Cash severance multiple: The agreement provides a lump sum equal to 2.0 times the average of the executive's annual base salary and bonus for the most recent two consecutive calendar years.
- Pro-rated bonus: A separate lump sum equal to the greater of the target annual bonus or the bonus that would have been earned based on performance through termination, pro-rated for actual days of service.
- COBRA coverage: Continued COBRA coverage for the executive and eligible spouse and dependents for 18 months is included in the severance package.
- Equity acceleration: All equity or equity-based incentive awards subject solely to time-based vesting would vest on an accelerated basis upon a qualifying termination.
- Non-compete and non-solicit: Restrictions on competition and solicitation of customers and employees apply during employment and, if severance is payable, for 12 months thereafter.
- 280G cutback provision: Payments will be reduced to the largest amount not subject to the Section 4999 excise tax if such reduction results in greater net after-tax proceeds to the executive.
National Health Investors Discloses Severance Terms for Christian Maingot
According to the filing, National Health Investors, Inc. (NYSE:NHI), a Maryland-incorporated real estate investment trust headquartered in Murfreesboro, Tennessee, entered into a Change in Control Severance Agreement with Christian Maingot on August 27, 2026. The agreement is triggered if the executive's employment is terminated by the company without "Cause," or by the executive for "Good Reason," within two years following a "Change in Control," or if terminated without "Cause" within 30 days prior to a "Change in Control," as each term is defined in the agreement.
The filing describes four categories of severance benefits. First, a lump sum cash payment equal to 2.0 times the average of annual base salary and bonus for the most recent two consecutive calendar years (or, if the executive has been employed for fewer than two calendar years, for the number of full calendar years of employment). Second, a pro-rated lump sum bonus payment equal to the greater of the target annual bonus or the bonus that would have been earned based on performance through the termination date. Third, 18 months of continued COBRA coverage for the executive, spouse, and dependents, as applicable. Fourth, accelerated vesting of all equity or equity-based incentive awards subject solely to time-based vesting.
The agreement also imposes non-competition and non-solicitation restrictions, covering customers and employees, that apply during the executive's employment and for 12 months after termination if severance benefits are payable. Confidentiality obligations continue indefinitely. The filing further states that if any payment would be subject to the excise tax under Section 4999 of the Internal Revenue Code, payments will be reduced to avoid that tax, but only if such reduction would result in greater net after-tax proceeds for the executive. The filing notes the description "does not purport to be complete" and refers to the full agreement filed as Exhibit 10.1.
What Was Disclosed
National Health Investors, Inc. reported entering into a Change in Control Severance Agreement with executive Christian Maingot, detailing cash severance, bonus, COBRA, equity acceleration, and restrictive covenant terms, all effective August 27, 2026.






Please wait processing your request...